4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.60
-0.09 (-1.04%)
At close: May 22, 2026, 4:00 PM EDT
8.57
-0.03 (-0.35%)
After-hours: May 22, 2026, 6:14 PM EDT
4D Molecular Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $40 → $21 | Strong Buy | Initiates | $40 → $21 | +144.19% | Mar 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +318.60% | Mar 20, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $35 | Buy | Maintains | $32 → $35 | +306.98% | Mar 19, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 | Strong Buy | Maintains | $26 | +202.33% | Mar 19, 2026 |
| Barclays | Barclays | Buy Initiates $33 | Buy | Initiates | $33 | +283.72% | Jan 28, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 | Strong Buy | Maintains | $26 | +202.33% | Dec 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $26 → $32 | Buy | Maintains | $26 → $32 | +272.09% | Nov 11, 2025 |
| Barclays | Barclays | Buy Maintains $38 → $33 | Buy | Maintains | $38 → $33 | +283.72% | Nov 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.